Form 4 for KROS Keros Therapeutics, Inc.
Accepted 2023-01-20 00:00:00 ET · period of report 2020-04-13 · accession 0001209191-23-004279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-20 | 2020-04-13 | KROS | Knowles Julius | Dir | P - Purchase | $20.98 | +1,191 | 1,191 | New | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2020-04-13 | P | A | 1,191 | $20.98 | 1,191 | D | — | — |